ArticleMolecular therapy. Advances2026

Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.

Rafik Boudra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.